H. Kim

Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer

J. Jo, J. Shin, M. Ryu, 2012, British Journal of Cancer.

Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy

A. Oshima, H. K. Kim, I. Choi, 2010, The Pharmacogenomics Journal.

The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression

S. Shin, H. Kim, C. Kim, 2022, ESMO open.